Travis J, Garner D, Bowen J
Biochemistry. 1978 Dec 26;17(26):5647-51. doi: 10.1021/bi00619a010.
Human alpha-1-antichymotrypsin has been purified to homogeneity by the following sequential steps--(a) ammonium sulfate fractionation; (b) chromatography on Cibacron Blue Sepharose at pH 7.0; and (c) chromatography on SP-Sephadex C-50 at pH 5.5. The inhibitor has a molecular weight near 68,000 and contains approximately 26% carbohydrate alpha-1-Antichymotrypsin has an amino-terminal arginine and a carboxy-terminal glycine. It also has some homology with alpha-1-PI based on amino-terminal sequence analysis of both proteins. Complexes of alpha-1-antichymotrypsin with human chymotrypsin and human leukocyte cathepsin G are stable in sodium dodecyl sulfate and have molecular weights near 90,000 suggesting 1:1 complex formation on a molar basis between inhibitor and enzyme.
人α1-抗糜蛋白酶已通过以下连续步骤纯化至均一状态:(a)硫酸铵分级分离;(b)在pH 7.0条件下于Cibacron Blue琼脂糖凝胶上进行层析;(c)在pH 5.5条件下于SP-葡聚糖凝胶C-50上进行层析。该抑制剂的分子量接近68,000,含有约26%的碳水化合物。α1-抗糜蛋白酶具有一个氨基末端精氨酸和一个羧基末端甘氨酸。基于两种蛋白质的氨基末端序列分析,它与α1-抗胰蛋白酶也有一些同源性。α1-抗糜蛋白酶与人胰凝乳蛋白酶和人白细胞组织蛋白酶G的复合物在十二烷基硫酸钠中稳定,分子量接近90,000,表明抑制剂与酶在摩尔基础上以1:1形成复合物。